PentaBind

PentaBind is designing high performance aptamers as therapeutic delivery vehicles and active ingredients. It uses generative artificial intelligence models, supported by wet-laboratory data generation processes, to help produce aptamer drugs that are easy to design, highly selective and ‘invisible’ to the immune system. Unlike many RNA drugs targeting mRNA, its aptamers overcome high gene turnover issues and endosomal escape challenges for effective tumour penetration.